Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
PMID 38158376
Future research should investigate the effects of GLP-1 and GLP-1/GIP agonists on alcohol consumption in different weight ranges and between different drug classes
It remains an investigational compound in Phase 3 clinical development
Thus, we have demonstrated that GSH-targeted therapy selectively kills PC cells in an oxidative stress-dependent manner and that the differences in basal ROS level and antioxidant scavenging capacity induced by stratified expression of VRK2 can well account for the heterogeneous sensitivity to GSH inhibition
US$ 21.08
US$ 20.73
US$ 22.11
US$ 23.03
